Drobaksh M 80mg/250mg Tablet
Marketer
Srb Life Science
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Drobaksh M 80mg/250mg Tablet
Abdominal pain is effectively managed by the combined medication, Drobaksh M 80mg/250mg tablets. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Administered with food, dosage and treatment duration should strictly follow your physician's instructions, tailored to your individual response and condition. Premature discontinuation may lead to symptom recurrence and worsening condition. Complete disclosure of all other medications is crucial, as interactions are possible. Common, generally transient side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, anorexia, thirst, and heartburn. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness may occur; refrain from operating machinery or engaging in activities requiring alertness until the medicine's effects are known. Alcohol consumption should be avoided due to increased dizziness risk. Inform your doctor about pregnancy, pregnancy plans, breastfeeding, kidney, or liver conditions to ensure appropriate dosage.
Primary Ingredients of Drobaksh M 80mg/250mg Tablet
No text provided. Please provide the text you wish to be rewritten.
Uses of Drobaksh M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Drobaksh M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Drobaksh M 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Drobaksh M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Drobaksh M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Drobaksh M 80mg/250mg tablets should be administered with a meal.
How Drobaksh M 80mg/250mg Tablet works:
Drobaksh M, an 80mg/250mg tablet, combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Drobaksh M 80mg/250mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Drobaksh M 80mg/250mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Drobaksh M 80mg/250mg tablets with breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
The medication Drobaksh M 80mg/250mg Tablet can induce adverse reactions, potentially impairing driving capabilities due to the possibility of dizziness.
KidneyCAUTION
Patients with impaired kidney function should use Drobaksh M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Drobaksh M 80mg/250mg tablets; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Drobaksh M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Drobaksh M 80mg/250mg Tablet :
Should you forget to take a Drobaksh M 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Drobaksh M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
3,018 People bought this recently